BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/20/2020 2:28:50 AM | Browse: 588 | Download: 718
 |
Received |
|
2020-01-18 11:01 |
|
Peer-Review Started |
|
2020-01-18 11:02 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-04-12 23:04 |
|
Revised |
|
2020-05-26 16:56 |
|
Second Decision |
|
2020-06-11 08:48 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-06-14 19:12 |
|
Articles in Press |
|
2020-06-14 19:12 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-07-03 05:41 |
|
Publish the Manuscript Online |
|
2020-07-20 02:28 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Complete response in anaplastic lymphoma kinase–rearranged oncocytic thyroid cancer: A case report and review of literature
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Victoire de Salins, Gokoulakrichenane Loganadane, Charlotte Joly, Mukedaisi Abulizi, Maya Nourieh, Hélène Boussion, Yazid Belkacemi, Christophe Tournigand and Emmanuelle Kempf |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Christophe Tournigand, MD, PhD, Chief Doctor, Full Professor, Department of Medical Oncology, Henri Mondor et Albert Chenevier Teaching Hospital, Assistance Publique – Hôpitaux de Paris, University of Paris-Est Creteil, 51 Avenue du Maréchal de Lattre de Tassigny, Créteil 94010, France. christophe.tournigand@aphp.fr |
| Key Words |
Oncocytic tumors of the thyroid; Hürthle cell tumors; Crizotinib; Precision; Medicine; Case report |
| Core Tip |
Oncocytic carcinoma of the thyroid is a rare disease, characterized by a poor prognosis and low response rate to radioiodine therapy. We present here a case of a 76-year-old woman who was diagnosed with metastatic oncocytic thyroid cancer. A rearrangement of the anaplastic lymphoma kinase (ALK) gene within the thyroid tumor was found, and the patient started a daily treatment of crizotinib, a specific ALK inhibitor. After 4 mo, an unexpected complete metabolic response was observed. The efficacy of crizotinib in an ALK-rearranged thyroid tumor is a promising therapeutic track and needs to be explored. |
| Publish Date |
2020-07-20 02:28 |
| Citation |
de Salins V, Loganadane G, Joly C, Abulizi M, Nourieh M, Boussion H, Belkacemi Y, Tournigand C, Kempf E. Complete response in anaplastic lymphoma kinase–rearranged oncocytic thyroid cancer: A case report and review of literature. World J Clin Oncol 2020; 11(7): 495-503 |
| URL |
https://www.wjgnet.com/2218-4333/full/v11/i7/495.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v11.i7.495 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
